Redox albuminomics: Oxidized albumin in human diseases

Antioxidants and Redox Signaling

Volumn 17, Issue 11, 2012, Pages 1515-1527

  Colombo, Graziano ^a   Clerici, Marco ^a,b   Giustarini, Daniela ^c   Rossi, Ranieri ^c   Milzani, Aldo ^a   Dalle Donne, Isabella ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CYSTEINE; THIOL;

ANTIOXIDANT ACTIVITY; BODY FLUID; CHROMATOGRAPHY; HUMAN; MASS SPECTROMETRY; OXIDATION; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN METABOLISM; REVIEW;

ALBUMINS; ANTIOXIDANTS; BODY FLUIDS; HUMANS; INFLAMMATION; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTEIN CARBONYLATION; PROTEINS; SULFHYDRYL COMPOUNDS;

EID: 84866840518     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2012.4702     Document Type: Review

References (84)

1. Agarwal R. On the nature of proteinuria with acute renal injury in patients with chronic kidney disease. Am J Physiol Renal Physiol 288: F265-F271, 2005. (Pubitemid 40105384)
2. Agarwal R. Anti-inflammatory effects of short-term pioglitazone therapy in men with advanced diabetic nephropathy. Am J Physiol Renal Physiol 290: F600-F605, 2006. (Pubitemid 43724959)
3. Aldini G, Vistoli G, Regazzoni L, Gamberoni L, Facino RM, Yamaguchi S, Uchida K, and Carini M. Albumin is the main nucleophilic target of human plasma: a protective role against pro-atherogenic electrophilic reactive carbonyl species? Chem Res Toxicol 21: 824-835, 2008. (Pubitemid 351644560)
4. Bar-Or D, Heyborne KD, Bar-Or R, Rael LT, Winkler JV, and Navot D. Cysteinylation of maternal plasma albumin and its association with intrauterine growth restriction. Prenat Diagn 25: 245-249, 2005. (Pubitemid 40478012)
5. Beck JL, Ambahera S, Yong SR, Sheil MM, de Jersey J, and Ralph SF. Direct observation of covalent adducts with Cys34 of human serum albumin using mass spectrometry. Anal Biochem 325: 326-336, 2004. (Pubitemid 38134370)
6. Boisvert MR, Koski KG, and Skinner CD. Increased oxidative modifications of amniotic fluid albumin in pregnancies associated with gestational diabetes mellitus. Anal Chem 82: 1133-1137, 2010.
7. Breusing N and Grune T. Biomarkers of protein oxidation from a chemical, biological and medical point of view. Exp Gerontol 45: 733-737, 2010.
8. Bruschi M, Petretto A, Candiano G, Musante L, Movilli E, Santucci L, Urbani A, Gusmano R, Verrina E, Cancarini G, Scolari F, and Ghiggeri GM. Determination of the oxidoredox status of plasma albumin in hemodialysis patients. J Chromatogr B Analyt Technol Biomed Life Sci 864: 29-37, 2008.
9. Capeillère-Blandin C, Gausson V, Descamps-Latscha B, and Witko-Sarsat V. Biochemical and spectrophotometric significance of advanced oxidized protein products. Biochim Biophys Acta 1689: 91-102, 2004. (Pubitemid 38766144)
10. Carballal S, Alvarez B, Turell L, Botti H, Freeman BA, and Radi R. Sulfenic acid in human serum albumin. Amino Acids 32: 543-551, 2007. (Pubitemid 46790936)
11. Colombo G, Aldini G, Orioli M, Colombo R, Giustarini D, Gornati R, Rossi R, Carini M, Milzani A, and Dalle-Donne I. Water-soluble a-b-unsaturated aldehydes of cigarette smoke induce carbonylation in human serum albumin. Antioxid Redox Signal 12: 349-364, 2010.
12. Curry S, Mandelkov H, Brick P, and Franks N. Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites. Nat Struct Biol 5: 827-835, 1998. (Pubitemid 28402087)
13. D'Aguanno S, Franciotta D, Lupisella S, Barassi A, Pieragostino D, Lugaresi A, Centonze D, D'Eril GM, Bernardini S, Federici G, and Urbani A. Protein profiling of Guillain-Barrè syndrome cerebrospinal fluid by two-dimensional electrophoresis and mass spectrometry. Neurosci Lett 485: 49-54, 2010.
14. Dalle-Donne I, Aldini G, Carini M, Colombo R, Rossi R, and Milzani A. Protein carbonylation, cellular dysfunction, and disease progression. J Cell Mol Med 10: 389-406, 2006. (Pubitemid 44870187)
15. Dalle-Donne I, Milzani A, Gagliano N, Colombo R, Giustarini D, and Rossi R. Molecular mechanisms and potential clinical significance of S-glutathionylation. Antioxid Redox Signal 10: 445-473, 2008.
16. Dalle-Donne I, Rossi R, Colombo R, Giustarini D, and Milzani A. Biomarkers of oxidative damage in human disease. Clin Chem 52: 601-623, 2006.
17. Dalle-Donne I, Rossi R, Giustarini D, Milzani A, and Colombo R. Protein carbonyl groups as biomarkers of oxidative stress. Clin Chim Acta 329: 23-38, 2003. (Pubitemid 36187411)
18. Dalle-Donne I, Scaloni A, and Butterfield DA. (Eds). Redox Proteomics: from Protein Modifications to Cellular Dysfunction and Disease. Hoboken, NJ: Wiley, 2006, p. 944.
19. Fanali G, di Masi A, Trezza V, Marino M, Fasano M, and Ascenzi P. Human serum albumin: from bench to bedside. Mol Aspects Med 33: 209-290, 2012.
20. Fasano M, Curry S, Terreno E, Galliano M, Fanali G, Narciso P, Notari S, and Ascenzi P. The extraordinary ligand binding properties of human serum albumin. IUBMB Life 57: 787-796, 2005. (Pubitemid 43062399)
21. Fukushima H, Miwa Y, Shiraki M, Gomi I, Toda K, Kuriyama S, Nakamura H, Wakahara T, Era S, and Moriwaki H. Oral branched-chain amino acid supplementation improves the oxidized/reduced albumin ratio in patients with liver cirrhosis. Hepatol Res 37: 765-770, 2007. (Pubitemid 47054783)
22. Giustarini D, Dalle-Donne I, Lorenzini S, Milzani A, and Rossi R. Age-related influence on thiol, disulfide and protein mixed disulfide levels in human plasma. J Gerontol A Biol Sci Med Sci 61: 1030-1038, 2006. (Pubitemid 44727210)
23. Giustarini D, Dalle-Donne I, Tsikas D, and Rossi R. Oxidative stress and human diseases: Origin, link, measurement, mechanisms, and biomarkers. Crit Rev Clin Lab Sci 46: 241-281, 2009.
24. Greilberger J, Koidl C, Greilberger M, Lamprecht M, Schroecksnadel K, Leblhuber F, Fuchs D, and Oettl K. Malondialdehyde, carbonyl proteins and albumin-disulphide as useful oxidative markers in mild cognitive impairment and Alzheimer's disease. Free Radic Res 42: 633-638, 2008.
25. Hackett TL, Scarci M, Zheng L, Tan W, Treasure T, and Warner JA. Oxidative modification of albumin in the parenchymal lung tissue of current smokers with chronic obstructive pulmonary disease. Respir Res 11: 180-189, 2010.
26. Himmelfarb J and McMonagle E. Albumin is the major plasma protein target of oxidant stress in uremia. Kidney Int 60: 358-363, 2001. (Pubitemid 32587575)
27. Hortin GL, Seam N, Gerard T, and Hoehn GT. Bound homocysteine, cysteine, and cysteinylglycine distribution between albumin and globulins. Clin Chem 52: 2258-2264, 2006. (Pubitemid 44925000)
28. Jiao K, Mandapati S, Skipper PL, Tannenbaum SR, and Wishnok JS. Site-selective nitration of tyrosine in human serum albumin by peroxynitrite. Anal Biochem 293: 43-52, 2001. (Pubitemid 32500504)
29. Joffe P and Henriksen JH. Bidirectional peritoneal transport of albumin in continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 10: 1725-1732, 1995.
30. Kawai K, Hayashi T, Matsuyama Y, Minami T, and Seiichi E. Difference in redox status of serum and aqueous humor in senile cataract patients as monitored via the albumin thiolredox state. Jpn J Ophthalmol 54: 584-588, 2010.
31. Kawakami A, Kubota K, Yamada N, Tagami U, Takehana K, Sonaka I, Suzuki E, and Hirayama K. Identification and characterization of oxidized human serum albumin. A slight structural change impairs its ligand-binding and antioxidant functions. FEBS J 273: 3346-3357, 2006. (Pubitemid 43990937)
32. Lemarechal H, Allanore Y, Chenevier-Gobeaux C, Kahan A, Ekindjian OG, and Borderie D. Serum protein oxidation in patients with rheumatoid arthritis and effects of infliximab therapy. Clin Chim Acta 372: 147-153, 2006. (Pubitemid 44286769)
33. Li HY, Hou FF, Zhang X, Chen PY, Liu SX, Feng JX, Liu ZQ, Shan YX,Wang GB, Zhou ZM, Tian JW, and Xie D Advanced oxidation protein products accelerate renal fibrosis in a remnant kidney model. J Am Soc Nephrol 18: 528-538, 2007. (Pubitemid 46193318)
34. Lim PS, Cheng YM, and Yang SM. Impairments of the biological properties of serum albumin in patients on haemodialysis. Nephrology 12: 18-24, 2007.
35. Liu SX, Hou FF, Guo ZJ, Nagai R, Zhang WR, Liu ZQ, Zhou ZM, Zhou M, Xie D, Wang GB, and Zhang X. Advanced oxidation protein products accelerate atherosclerosis through promoting oxidative stress and inflammation. Arterioscler Thromb Vasc Biol 26: 1156-1162, 2006. (Pubitemid 43732127)
36. Marsche G, Frank S, Hrzenjak A, Holzer M, Dirnberger S, Wadsack C, Scharnagl H, Stojakovic T, Heinemann A, and Oettl K. Plasma-Advanced Oxidation Protein Products are potent high-density lipoprotein receptor antagonists in vivo. Circ Res 104: 750-757, 2009.
37. McCarty DJ. Synovial fluid. In: Arthritis and Allied Conditions: a Textbook of Rheumatology, edited by Koopman WJ, 13th edition, vol. 1. Baltimore, MD: Williams & Wilkins, 1997, pp. 81-102.
38. Mera K, Anraku M, Kitamura K, Nakajou K, Maruyama T, and Otagiri M. The structure and function of oxidized albumin in hemodialysis patients: Its role in elevated oxidative stress via neutrophil burst. Biochem Biophys Res Commun 334: 1322-1328, 2005. (Pubitemid 41074719)
39. Mera K, Anraku M, Kitamura K, Nakajou K, Maruyama T, Tomita K, and Otagiri M. Oxidation and carboxy methyl lysine-modification of albumin: possible involvement in the progression of oxidative stress in hemodialysis patients. Hypertens Res 28: 973-980, 2005.
40. Mitrogianni Z, Barbouti A, Galaris D, and Siamopoulos KC. Oxidative modification of albumin in predialysis, hemodialysis, and peritoneal dialysis patients. Nephron Clin Pract 113: c234-c240, 2009.
41. Moon GJ, Shin DH, Im DS, Bang OY, Nam HS, Lee JH, Joo IS, Huh K, and Gwag BJ. Identification of oxidized serum albumin in the cerebrospinal fluid of ischaemic stroke patients. Eur J Neurol 18: 1151-1158, 2011.
42. Morgan PE, Sturgess AD, and Davies MJ Evidence for chronically elevated serum protein oxidation in systemic lupus erythematosus patients. Free Radic Res 43: 117-127, 2009.
43. Murphy MP, Holmgren A, Larsson NG, Halliwell B, Chang CJ, Kalyanaraman B, Rhee SG, Thornalley PJ, Partridge L, Gems D, Nyström T, Belousov V, Schumacker PT, and Winterbourn CC. Unraveling the biological roles of reactive oxygen species. Cell Metab 13: 361-366, 2011.
44. Musante L, Bruschi M, Candiano G, Petretto A, Dimasi N, Del Boccio P, Urbani A, Rialdi G, and Ghiggeri GM. Characterization of oxidation end product of plasma albumin "in vivo." Biochem Biophys Res Commun 349: 668-673, 2006.
45. Musante L, Candiano G, Petretto A, Bruschi M, Dimasi N, Caridi G, Pavone B, Del Boccio P, Galliano M, Urbani A, Scolari F, Vincenti F, and Ghiggeri GM. Active focal segmental glomerulosclerosis is associated with massive oxidation of plasma albumin. J Am Soc Nephrol 18: 799-810, 2007. (Pubitemid 46434497)
46. Nagai K, Betsuyaku T, Kondo T, Nasuhara Y, and Nishimura M. Long term smoking with age builds up excessive oxidative stress in bronchoalveolar lavage fluid. Thorax 61: 496-502, 2006. (Pubitemid 43901519)
47. Nagai K, Betsuyaku T, Konno S, Ito Y, Nasuhara Y, Hizawa N, Kondo T, and Nishimura M. Diversity of protein carbonylation in allergic airway inflammation. Free Radic Res 42: 921-929, 2008.
48. Noel-Georis I, Bernard A, Falmagne P, and Wattiez R. Database of bronchoalveolar lavage fluid proteins. J Chromatogr B Analyt Technol Biomed Life Sci 771: 221-236, 2002. (Pubitemid 34457730)
49. Oettl K and Marsche G. Redox state of human serum albumin in terms of cysteine-34 in health and disease. Methods Enzymol 474: 181-195, 2010.
50. Oettl K, Stadlbauer V, Krisper P, and Stauber RE. Effect of extracorporeal liver support by molecular adsorbents recirculating system and prometheus on redox state of albumin in acute-on-chronic liver failure. Ther Apher Dial 13: 431-436, 2009.
51. Oettl K, Stadlbauer V, Petter F, Greilberger J, Putz-Bankuti C, Hallstrom S, Lackner C, and Stauber RE. Oxidative damage of albumin in advanced liver disease. Biochim Biophys Acta 1782: 469-473, 2008.
52. Oettl K and Stauber RE. Physiological and pathological changes in the redox state of human serum albumin critically influence its binding properties. Br J Pharmacol 151: 580-590, 2007. (Pubitemid 47016287)
53. Oettl, K, Reibnegger G, and Schmut O. The redox state of human serum albumin in eye diseases with and without complications. Acta Ophthalmol 89: e174-e179, 2011.
54. Pavone B, Sirolli V, Bucci S, Libardi F, Felaco P, Amoroso L, Sacchetta P, Urbani A, and Bonomini M. Adsorption and carbonylation of plasma proteins by dialyser membrane material: in vitro and in vivo proteomics investigations. Blood Transfus 3: S113-S119, 2010.
55. Pavone B, Sirolli V, Giardinelli A, Bucci S, Forl?̀ F, Di Cesare M, Sacchetta P, Di Pietro N, Pandolfi A, Urbani A, and Bonomini M. Plasma protein carbonylation in chronic uremia. J Nephrol 24: 453-464, 2011.
56. Peters T, Jr. The albumin molecule: Structure and chemical properties. In: All About Albumin: Biochemistry, Genetics, and Medical Applications, edited by Peters T, Jr. San Diego, CA: Academic Press, 1996, pp. 9-75.
57. Piroddi M, Palmese A, Pilolli F, Amoresano A, Pucci P, Ronco C, and Galli F. Plasma nitroproteome of kidney disease patients. Amino Acids 40: 653-667, 2011.
58. Predescu DN, Predescu SA, and Malik AB. Transport of nitrated albumin across continuous vascular endothelium. Proc Natl Acad Sci USA 99: 13932-13937, 2002. (Pubitemid 35215483)
59. Quinlan GJ, Mumby S, Martin GS, Bernard GR, Gutteridge JM, and Evans TW. Albumin influences total plasma antioxidant capacity favorably in patients with acute lung injury. Crit Care Med 32: 755-759, 2004. (Pubitemid 38340073)
60. Rasheed Z, Ahmad R, and Ali R. Structure and immunological function of oxidised albumin in lung cancer: its potential role as a biomarker of elevated oxidative stress. Br J Biomed Sci 66: 67-73, 2009.
61. Rasheed Z, Ahmad R, Rasheed N, and Ali R. Reactive oxygen species damaged human serum albumin in patients with hepatocellular carcinoma. J Exp Clin Cancer Res 26: 395-404, 2007. (Pubitemid 47584817)
62. Rasheed Z and Ali R. Reactive oxygen species damaged human serum albumin in patients with type 1 diabetes mellitus: biochemical and immunological studies. Life Sci 79: 2320-2328, 2006. (Pubitemid 44666070)
63. Roche M, Rondeau P, Singh NR, Tarnus E, and Bourdon E. The antioxidant properties of serum albumin. FEBS Lett 582: 1783-1787, 2008.
64. Roche S, Gabelle A, and Lehmann S. Clinical proteomics of the cerebrospinal fluid: towards the discovery of new biomarkers. Proteomics Clin Appl 2: 428-436, 2008. (Pubitemid 351425370)
65. Rossi R, Giustarini D, Milzani A, and Dalle-Donne I. Cysteinylation and homocysteinylation of plasma protein thiols during ageing of healthy human beings. J Cell Mol Med 13: 3131-3140, 2009.
66. Selmeci L, Székely M, Soó s P, Seres L, Klinga N, Geiger A, and Acsády G. Human blood plasma advanced oxidation protein products (AOPP) correlates with fibrinogen levels. Free Radic Res 40: 952-958, 2006. (Pubitemid 44480558)
67. Selmeci L. Advanced oxidation protein products (AOPP): novel uremic toxins, or components of the non-enzymatic antioxidant system of the plasma proteome? Free Radic Res 45: 1115-1123, 2011.
68. Sheikh Z, Ahmad R, Sheikh N, and Ali R. Enhanced recognition of reactive oxygen species damaged human serum albumin by circulating systemic lupus erythematosus autoantibodies. Autoimmunity 40: 512-520, 2007. (Pubitemid 351233172)
69. Shi XY, Hou FF, Niu HX, Wang GB, Xie D, Guo ZJ, Zhou ZM, Yang F, Tian JW, and Zhang X. Advanced oxidation protein products promote inflammation in diabetic kidney through activation of renal nicotinamide adenine dinucleotide phosphate oxidase. Endocrinology 149: 1829-1839, 2008. (Pubitemid 351468323)
70. Soejima A, Matsuzawa N, Hayashi T, Kimura R, Ootsuka T, Fukuoka K, Yamada A, Nagesawa T, and Era S. Alteration of redox state of human serum albumin before and after hemodialysis. Blood Purif 22: 525-529, 2004. (Pubitemid 40069622)
71. Starosta V and Griese M. Protein oxidation by chronic pulmonary diseases in children. Pediatr Pulmonol 41: 67-73, 2006. (Pubitemid 43117370)
72. Stewart AJ, Blindauer CA, Berezenko S, Sleep D, Tooth D, and Sadler PJ. Role of Tyr84 in controlling the reactivity of Cys34 of human albumin. FEBS J 272: 353-362, 2005.
73. Sugio S, Kashima A, Mochizuki S, Noda M, and Kobayashi K. Crystal structure of human serum albumin at 2.5 A resolution. Protein Eng 12: 439-446, 1999. (Pubitemid 29322441)
74. Suzuki M, Betsuyaku T, ItoY, Nagai K, Nasuhara Y, Kaga K, Kondo S, and Nishimura M. Down-regulated NF-E2-related factor 2 in pulmonary macrophages of aged smokers and patients with Chronic Obstructive Pulmonary Disease. Am J Respir Cell Mol Biol 39: 673-682, 2008.
75. Terawaki H, Takada Y, Era S, Funakoshi Y, Nakayama K, Nakayama M, Ogura M, Ito S, and Hosoya T. The redox state of albumin and serious cardiovascular incidence in hemodialysis patients. Ther Apher Dial 14: 465-471, 2010.
76. Terawaki H, Yoshimura K, Hasegawa T, Matsuyama Y, Negawa T, Yamada K, Matsushima M, Nakayama M, Hosoya T, and Era S. Oxidative stress is enhanced in correlation with renal dysfunction: examination with the redox state of albumin. Kidney Int 66: 1988-1993, 2004.
77. Torres MJ, Turell L, Botti H, Antmann L, Carballal S, Ferrer-Sueta G, Radi R, and Alvarez B. Modulation of the reactivity of the thiol of human serum albumin and its sulfenic derivative by fatty acids. Arch Biochem Biophys 521: 102-110, 2012.
78. Tsikas D, Sandmann J, and Frö lich JC. Measurement of Snitrosoalbumin by gas chromatography-mass spectrometry. III. Quantitative determination in human plasma after specific conversion of the S-nitroso group to nitrite by cysteine and Cu(2 + ) via intermediate formation of S-nitrosocysteine and nitric oxide. J Chromatogr B Analyt Technol Biomed Life Sci 772: 335-346, 2002. (Pubitemid 34499581)
79. Turell L, Botti H, Carballal S, Ferrer-Sueta G, Souza JM, Durán R, Freeman BA, Radi R, and Alvarez B. Reactivity of sulfenic acid in human serum albumin. Biochemistry 47: 358-367, 2008.
80. Turell L, Botti H, Carballal S, Radi R, and Alvarez B. Sulfenic acid-A key intermediate in albumin thiol oxidation. J Chromatogr B Analyt Technol Biomed Life Sci 877: 3384-3392, 2009.
81. Watanabe A, Matsuzaki S, Moriwaki H, Suzuki K, and Nishiguchi S. Problems in serum albumin measurement and clinical significance of albumin microheterogeneity in cirrhotics. Nutrition 20: 351-357, 2004. (Pubitemid 38388508)
82. Wayenberg JL, Cavedon C, Ghaddhab C, Lefèvre N, and Bottari SP. Early transient hypoglycemia is associated with increased albumin nitration in the preterm infant. Neonatology 100: 387-397, 2011.
83. Wayenberg JL, Ransy V, Vermeylen D, Damis E, and Bottari SP. Nitrated plasma albumin as a marker of nitrative stress and neonatal encephalopathy in perinatal asphyxia. Free Radic Biol Med 47: 975-982, 2009.
84. Zurawa-Janicka D, Renke J, Popadiuk S, Skorko-Glonek J, Szumera M, Plata-Nazar K, Ulko P, Wozniak M, and Lipinska B. Preferential immunoglobulin oxidation in children with juvenile idiopathic arthritis. Scand J Rheumatol 35: 193-200, 2006. (Pubitemid 43890739)